Skip to main content
Clinical Trials/NCT02035410
NCT02035410
Completed
Not Applicable

Phase 1 Study of Prevention of Cardiac Device Implantation Site Infection

Yong Seog Oh1 site in 1 country352 target enrollmentDecember 2013
ConditionsInfection

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Infection
Sponsor
Yong Seog Oh
Enrollment
352
Locations
1
Primary Endpoint
freedom of cardiac device-related infection
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Cardiovascular implantable electronic device (CIED) infections have been increasing out of proportion to the number of devices implanted We investigated recent trends and possible causes of the increasing numbers of Cardiovascular implantable electronic device infections.

Detailed Description

There are many studies on the preventive use of Antibiotics or povidone iodine to Cardiovascular implantable electronic device (CIED) infections. But, studies of prophylactic use of hydrogen peroxide is still limited. We had planned research on effects of preventive using hydrogen peroxide before cardiac devices insertion.

Registry
clinicaltrials.gov
Start Date
December 2013
End Date
October 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Yong Seog Oh
Responsible Party
Sponsor Investigator
Principal Investigator

Yong Seog Oh

ph.D

Seoul St. Mary's Hospital

Eligibility Criteria

Inclusion Criteria

  • scheduled for cardiac devices Implantation

Exclusion Criteria

  • under the age of 18
  • Hydrogen peroxide allergy
  • take an antibiotic
  • History of infection within 30 days

Outcomes

Primary Outcomes

freedom of cardiac device-related infection

Time Frame: 1 year after precedure

check the symptoms of infection. If have symptoms of infection : check the fever, heart rate, respiration rate, blood test, EKG

Study Sites (1)

Loading locations...

Similar Trials